Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8373211 | 0.94 | FDPS (0.42) | FDPSTSHRLMNATHRBSMPD1 | |
| SCHEMBL7523940 | 0.94 | FDPS (0.46) | FDPSTSHRTHRBSMPD1DNM1 | |
| SCHEMBL30081365 | 0.91 | SMPD1 (0.48) | FDPSTSHRTHRBSMPD1DNM1 | |
| SCHEMBL30081417 | 0.91 | SMPD1 (0.48) | FDPSTSHRTHRBSMPD1DNM1 | |
| SCHEMBL30081369 | 0.91 | SMPD1 (0.48) | FDPSTSHRTHRBSMPD1DNM1 | |
| SCHEMBL30081401 | 0.91 | SMPD1 (0.48) | FDPSTSHRTHRBSMPD1DNM1 | |
| SCHEMBL7623988 | 0.90 | FDPS (0.48) | FDPSTSHRTHRBSMPD1DNM1 | |
| SCHEMBL5172089 | 0.87 | — | — | |
| SCHEMBL49451 | 0.87 | SMPD1 (0.50) | FDPSTSHRTHRBSMPD1DNM1 | |
| SCHEMBL11521357 | 0.87 | SMPD1 (0.50) | FDPSTSHRTHRBSMPD1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3302770-B1 | METHOD FOR PREPARING AN ASSYMETRIC MEMBRANE | UNIV LEUVEN KATH (BE) | 2024-12-04 | — | — | EP | claimed |
| EP-3651855-B1 | NAIL HARDENING COMPOSITION AND METHOD OF USE | WELLA OPERATIONS US LLC (US) | 2022-10-05 | — | — | EP | claimed |
| EP-3763769-B1 | METHOD FOR PREPARING COPOLYAMIDE RESIN AND COPOLYAMIDE HOT-MELT YARN | UNIV WENZHOU (CN) | 2022-07-27 | — | — | EP | claimed |
| EP-4355803-A1 | POLYAMINES AS ALDEHYDE SCAVENGERS | BASF SE (DE) | 2024-04-24 | — | — | EP | disclosed |
| WO-2022263229-A1 | POLYAMINES AS ALDEHYDE SCAVENGERS | BASF SE (DE) | 2022-12-22 | — | — | WO | disclosed |
| US-10323002-B2 | Process for the preparation of histamine H3 receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2019-06-18 | — | — | US | disclosed |
| US-20180022704-A1 | PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2018-01-25 | — | — | US | disclosed |
| US-5476544-A | Dispersing agent | TOYO INK MANUFACTURING CO., LTD. (JP) | 1995-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10323002-B2 | Process for the preparation of histamine H3 receptor modulators | HRH3, HRH4, HRH1 | FDPS 4114/4885TSHR 377/4885LMNA 4494/4885 |
| US-20180022704-A1 | PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS | HRH3, HRH4, HRH1 | FDPS 4114/4885TSHR 377/4885LMNA 4494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.